SCHEMBL6673468

SCHEMBL6673468

C[C@H]1OC(OC(=O)c2ccccc2)[C@H](OC(=O)c2ccccc2)[C@@H]1OC(=O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LGALS9 O00182 1/20 0.44
▸ LGALS1 P09382 1/20 0.44
▸ LGALS3 P17931 1/20 0.44
▸ LGALS7; LGALS7B P47929 1/20 0.44
▸ TSHR P16473 2/20 0.43
▸ F2 P00734 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ PTPN1 P18031 2/20 0.40
▸ CHRNA7 P36544 2/20 0.40
▸ HTR3E A5X5Y0 1/20 0.40
▸ HTR3B O95264 1/20 0.40
▸ HTR3A P46098 1/20 0.40
▸ HTR3D Q70Z44 1/20 0.40
▸ HTR3C Q8WXA8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6673470 1.00 LGALS9 (0.44) LGALS9LGALS1LGALS3LGALS7; LGALS7BTSHR
SCHEMBL1521648 0.98 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BTSHR
SCHEMBL14110323 0.98 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BTSHR
SCHEMBL15520933 0.98 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BTSHR
SCHEMBL14268496 0.98 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BTSHR
SCHEMBL19591671 0.98 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BTSHR
SCHEMBL13714182 0.98 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BTSHR
SCHEMBL14293976 0.98 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BTSHR
SCHEMBL3780804 0.98 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BTSHR
SCHEMBL8819195 0.92 ABCB1 (0.42) LGALS9LGALS1LGALS3LGALS7; LGALS7BTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1057831-B1 Process for the preparation of vinyl pyrimidine derivatives HOFFMANN LA ROCHE (CH) 2004-09-22 — — EP disclosed
EP-1060183-B1 5'-DEOXYCYTIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-04-23 — — EP disclosed
US-6437118-B1 REACTING 4-AMINO-1H-PYRMIDIN-2-ONE WITH VINYL BORANE IN PRESENCE OF PALLADIUM COMPLEX AND BASE HOFFMANN-LA ROCHE INC. 2002-08-20 — — US disclosed
US-6211166-B1 COADMINISTERED WITH A 5-FLUOROURACIL DERIVATIVE; ANTICARCINOGENIC AGENTS HOFFMAN-LA ROCHE INC. 2001-04-03 — — US disclosed
EP-1060183-A1 5'-DEOXYCYTIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-12-20 — — EP disclosed
EP-1057831-A2 Process for the preparation of vinyl pyrimidine derivatives F. HOFFMANN-LA ROCHE AG (CH) 2000-12-06 — — EP disclosed
US-6114520-A ANTITUMOR AGENTS HOFFMANN-LA ROCHE INC. (US) 2000-09-05 — — US disclosed
WO-1999040099-A1 5'-DEOXYCYTIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1999-08-12 — — WO disclosed
Send feedback